Literature DB >> 15638063

Effectiveness and safety of infliximab combined with leflunomide in chronic polyarthritis.

A M Ortiz García, I González-Alvaro, R Roselló Pardo, L Carmona, M D Fábregas Canales, I Monteagudo Saez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15638063

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  5 in total

1.  [Leflunomide in combination with TNF-blockers for Methotrexate intolerance].

Authors:  K Krüger; B Manger
Journal:  Z Rheumatol       Date:  2009-03       Impact factor: 1.372

2.  Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha.

Authors:  Renato De Stefano; Elena Frati; Fernando Nargi; Caterina Baldi; Luana Menza; Mohammed Hammoud; Mauro Galeazzi
Journal:  Clin Rheumatol       Date:  2010-01-16       Impact factor: 2.980

Review 3.  Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing.

Authors:  Nicola Alcorn; Sarah Saunders; Rajan Madhok
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 4.  Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis.

Authors:  Peter Bb Jones; Douglas Hn White
Journal:  Open Access Rheumatol       Date:  2010-11-03

5.  Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort.

Authors:  Isidoro González-Alvaro; Miguel Angel Descalzo; Loreto Carmona
Journal:  Arthritis Res Ther       Date:  2008-11-26       Impact factor: 5.156
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.